Morepen Laboratories' Stock Reaches 52-Week High, Outperforms Sector and Sensex

Morepen Laboratories, a midcap pharmaceutical company, has been making waves in the stock market with its recent surge in stock price. On September 9th, the company's stock reached a 52-week high of Rs.98, marking a significant milestone for the company.

This positive trend has caught the attention of investors and market experts, with MarketsMOJO giving a 'Buy' call for the stock. The stock has also outperformed the sector by 6.18% today, showing its strong performance in the market.

The day's trading saw the stock reach an intraday high of Rs.98, a 9.69% increase from its previous closing price. However, it also touched an intraday low of Rs.85.16, showing some volatility in its trading. Despite this, the stock has been trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend for the company.

In the past year, Morepen Laboratories has shown an impressive performance of 142.10%, outshining the Sensex's performance of 22.20%. This further highlights the company's growth and potential in the pharmaceutical industry.

With its strong performance and positive outlook, Morepen Laboratories is definitely a company to watch out for in the midcap segment. Investors can consider adding this stock to their portfolio for potential growth and returns.